Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

shankar besta

  • Home
  • Author: shankar besta

Global travel and tourism deal activity up 4.6% in Q1-Q3 2022 but suffers decline in recent months, reveals GlobalData

The global travel and tourism sector saw the announcement of 793 deals (comprising mergers & acquisitions [M&A], private equity, and venture financing deals) in Q1-Q3 2022, recording a 4.6% growth compared to 758 deals in Q1-Q3 2021. However, when considering the month-on-month trend, the sector witnessed a consistent decline in deal activity in recent months, […]
Read more

India to lead styrene-butadiene rubber capacity additions in Asia through 2026, forecasts GlobalData

India is set to lead the styrene-butadiene rubber (SBR) capacity additions in Asia, contributing to about 98% of the region’s capacity additions in 2026, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Styrene-Butadiene-Rubber (SBR) Industry Installed Capacity and Capital Expenditure (CapEx) Market Forecast by Region and Countries including details of All Active […]
Read more

Rapidly growing M&A activity will propel metaverse market to record CAGR of 39.8% during 2022 to 2030, says GlobalData

The metaverse market will register a compound annual growth rate (CAGR) of 39.8% during the 2022-30 forecast period, driven by rapidly growing mergers and acquisitions (M&A) activity in the sector, says GlobalData, a leading data and analytics company. GlobalData’s latest report, “Metaverse Market Size, Share, Trends, Analysis and Forecasts, 2022-2030 reveals that M&A deals have […]
Read more

Taiwan life insurance industry to reach $135 billion in 2026, supported by foreign currency-denominated insurance, forecasts GlobalData

The Taiwanese life insurance industry will grow at a compound annual growth rate (CAGR) of 3.3% from TWD2.9 trillion ($106 billion) in 2021 to TWD3.5 trillion ($135 billion) in 2026, in terms of direct written premiums (DWP), supported by foreign currency-denominated insurance, and the establishment of internet-only life insurers, predicts GlobalData, a leading data and […]
Read more

Asia to dominate global styrene-butadiene rubber capacity additions through 2026, forecasts GlobalData

Asia is set to lead the global styrene-butadiene rubber (SBR) industry capacity additions with a share of 98%, driven by the addition of capacities from new-build and expansion projects between 2022 and 2026, forecasts GlobalData, a leading data and analytics company. GlobalData’s latest report “Styrene-Butadiene-Rubber (SBR) Industry Installed Capacity and Capital Expenditure (CapEx) Market Forecast […]
Read more

Simpson Thacher & Bartlett and Kirkland & Ellis top M&A legal advisers for Q1-Q3 2022, finds GlobalData

Simpson Thacher & Bartlett and Kirkland & Ellis were the top mergers and acquisition (M&A) legal advisers by value and volume in Q1-Q3 2022, respectively, according to the latest Legal Advisers League Table by GlobalData. According to the leading data and analytics company’s Financial Deals Database, Simpson Thacher & Bartlett achieved its leading position by […]
Read more

Singapore enterprises raise ICT budgets for 2022, driven by institutional support for digital economy, finds GlobalData survey

Encouraged by the government measures supporting growth in the digital economy along with continued efforts at digitalizing their own business operations, more than a third of enterprises in Singapore have significantly increased their ICT budgets in 2022 compared to 2021, reveals GlobalData, a leading data and analytics company. GlobalData’s Singapore enterprise ICT investment trends report, […]
Read more

Twitter Influencers cheer as US president pardons all convicted for marijuana possession, reveals GlobalData

US President Joe Biden announced key steps to mend the policy on marijuana on 6 October 2022, ahead of the midterm election. The announcement also includes pardoning thousands of those convicted of federal offenses on marijuana. Against this backdrop, a dramatic spike was noticed in Twitter Influencers’ conversations over ‘marijuana’, reveals the Social Media Analytics […]
Read more

Auceliciclib’s Phase II trial in Australia to test its potential to become ground-breaking therapy for glioblastoma, says GlobalData

Aucentra Therapeutics recently initiated a Phase II trial of auceliciclib in combination with temozolomide for recurrent or newly diagnosed glioblastoma patients in Australia. Auceliciclib is a CDK4/6 inhibitor and has proven its ability to overcome the blood-brain barrier (BBB) in preclinical models. Against this backdrop, auceliciclib could become a ground-breaking drug for glioblastoma if it […]
Read more
1 … 131 132 133 134 135 136